title: Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients.
authors.forename: Raquel
authors.initials: R
authors.lastname: Inocêncio da Luz
authors.forename: Gustavo A S
authors.initials: GA
authors.lastname: Romero
authors.forename: Maria Elizabeth
authors.initials: ME
authors.lastname: Dorval
authors.forename: Israel
authors.initials: I
authors.lastname: Cruz
authors.forename: Carmen
authors.initials: C
authors.lastname: Cañavate
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Dujardin
authors.forename: Tim
authors.initials: T
authors.lastname: Van Assche
authors.forename: Paul
authors.initials: P
authors.lastname: Cos
authors.forename: Louis
authors.initials: L
authors.lastname: Maes
mesh_terms: D000965:Antimony / Q000494:pharmacology*; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D001938:Brazil; D015658:HIV Infections / Q000150:complications; D006801:Humans; D020128:Inhibitory Concentration 50; D018314:Leishmania infantum / Q000187:drug effects* / Q000302:isolation & purification; D007898:Leishmaniasis, Visceral / Q000469:parasitology*; D021261:Parasitic Sensitivity Tests
chemical_list: D000981:Antiprotozoal Agents; D000965:Antimony